CNS Drugs
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.0 | Q1 | 92.9% | 2.161 | Q1 | 95.9% |
| 2024 | 7.4 | Q1 | 95.5% | 1.884 | Q1 | 94.8% |
| 2023 | 7.4 | Q1 | 94.7% | 1.616 | Q1 | 93.6% |
| 2022 | 6.0 | Q1 | 84.1% | 1.485 | Q1 | 92.9% |
| 2021 | 6.5 | Q1 | 84.9% | 1.263 | Q1 | 90.8% |
| 2020 | — | — | 1.565 | Q1 | 92.9% | |
| 2019 | — | — | 1.522 | Q1 | 92.8% | |
| 2018 | — | — | 1.553 | Q1 | 92.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1172-7047
ISSN
1179-1934
country
CHcoverage
1994-2026